APIAM ANIMAL HEALTH LIMITED (AHX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AHX

AHX - APIAM ANIMAL HEALTH LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 4.15
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.80

29 Aug
2025

0.010

OPEN

$0.78

1.27%

HIGH

$0.80

266,713

LOW

$0.78

OTHER COMPANIES IN THE SAME SECTOR
ACL . ALC . BMT . DOC . EBO . HLS . IDX . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 17/09 - ex-div 1.2c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx0.5
DPS All xxxxxxxxxxxxxxx2.0
Sales/Revenue xxxxxxxxxxxxxxx206.9 M
Book Value Per Share xxxxxxxxxxxxxxx66.1
Net Operating Cash Flow xxxxxxxxxxxxxxx17.6 M
Net Profit Margin xxxxxxxxxxxxxxx0.40 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx0.68 %
Return on Invested Capital xxxxxxxxxxxxxxx0.38 %
Return on Assets xxxxxxxxxxxxxxx0.33 %
Return on Equity xxxxxxxxxxxxxxx0.68 %
Return on Total Capital xxxxxxxxxxxxxxx5.47 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx9.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx6 M
Long Term Debt xxxxxxxxxxxxxxx97 M
Total Debt xxxxxxxxxxxxxxx103 M
Goodwill - Gross xxxxxxxxxxxxxxx147 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx3 M
Price To Book Value xxxxxxxxxxxxxxx0.79

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx6.8 M
Capex % of Sales xxxxxxxxxxxxxxx3.29 %
Cost of Goods Sold xxxxxxxxxxxxxxx173 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx22 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

20/08/2025

3

Downgrade to Hold from Buy

$0.88

10.00%

Apiam Animal Health has received a non-binding indicative proposal from Adamantem Capital to acquire all shares at 88cps, valuing the company at $162m.

Canaccord Genuity notes this represents a 64% premium to the last traded price. The proposal includes a rollover option into unlisted shares and is conditional on exclusivity for due diligence.

The broker notes Adamantem has secured a call option over around 19.9% of shares held by founder Chris Richards, exercisable only if a competing proposal emerges. An Independent Board Committee has been formed to assess the offer alongside other inbound interest.

Canaccord highlights the 11.9 times FY25 earnings (EBITDA) multiple compares with previous veterinary sector acquisitions, which ranged between 9.8-13.1 times.

General Vet clinics make up around 65% of Apiam’s business, with the balance across equine, feedlot and laboratory services.

The broker raises its target price to 88c from 63c and downgrades to Hold from Buy.

FORECAST
Canaccord Genuity forecasts a full year FY25 dividend of 2.00 cents and EPS of 3.40 cents.
Canaccord Genuity forecasts a full year FY26 dividend of 2.00 cents and EPS of 4.00 cents.
Access Extra Coverage Research History >

AHX STOCK CHART

FNArena News on AHX

1
In Case You Missed It – BC Extra Upgrades & Downgrades – 22-08-25

Aug 22 2025 - Weekly Reports
2
Australian Broker Call *Extra* Edition – Aug 20, 2025

Aug 20 2025 - Daily Market Reports
3
In Case You Missed It – BC Extra Upgrades & Downgrades – 28-03-25

Mar 28 2025 - Weekly Reports
4
Australian Broker Call *Extra* Edition – Mar 26, 2025

Mar 26 2025 - Daily Market Reports
5
Next Week At A Glance – 14-17 Oct 2024

Oct 11 2024 - Weekly Reports

Latest Healthcare services News

1
Better Times Ahead For Sonic Healthcare?

Jun 20 2025 - Australia
2
The Significance Of Cosmetique’s ASX Listing

Feb 26 2025 - Small Caps
3
Building The No 3 Diagnostic Imaging Player

Jun 19 2024 - Small Caps
4
Capitol Health’s Higher Margin Outlook

Mar 13 2024 - Small Caps
5
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
6
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
7
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
8
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
9
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
10
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps